Trials / Completed
CompletedNCT00310505
Amphotericin B Treatment in Visceral Leishmaniasis
Randomised Double Blind Dose Ranging Study of Amphotericin B in Visceral Leishmaniasis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,500 (planned)
- Sponsor
- Banaras Hindu University · Academic / Other
- Sex
- All
- Age
- 2 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.
Detailed description
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amphotericin B deoxycholate given as daily administration |
Timeline
- Start date
- 2003-01-01
- First posted
- 2006-04-04
- Last updated
- 2008-09-12
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT00310505. Inclusion in this directory is not an endorsement.